MarketCap
Facebook
X
TelegramGeschäftsbericht 2024
hinzugefügt 13.12.2025
Enlivex Therapeutics Ltd. EV 2011-2025 | ENLV
EV Jährlich Enlivex Therapeutics Ltd.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 122 M | 122 M | 74.9 M | 22.7 M | 59.1 M | 9.74 M | 54.4 M | 91.6 M | -139 K | -65 K | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 122 M | -139 K | 55.6 M |
EV anderer Aktien in der Pharmaeinzelhändler
| Name | EV | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
MorphoSys AG
MOR
|
1.82 B | - | 2.43 % | $ 254 M |  Germany |
 |
Arbutus Biopharma Corporation
ABUS
|
457 M | $ 4.85 | 3.03 % | $ 805 M |  Canada |
 |
Aclaris Therapeutics
ACRS
|
192 M | $ 3.24 | -0.46 % | $ 250 M |  USA |
 |
AlloVir
ALVR
|
-64.1 M | - | 4.14 % | $ 49.1 M | USA |
 |
Aptevo Therapeutics
APVO
|
3.01 M | $ 1.06 | -6.19 % | $ 293 K | USA |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
1.95 B | - | - | $ 40.3 B | USA |
 |
Ascendis Pharma A/S
ASND
|
726 M | $ 216.6 | -1.74 % | $ 5 B |  Danmark |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
3.41 B | - | -1.52 % | $ 24.7 M | USA |
 |
Midatech Pharma plc
MTP
|
4.79 M | - | -18.52 % | $ 27.3 M |  Britain |
 |
Alterity Therapeutics Limited
ATHE
|
-28.9 M | $ 3.14 | -4.56 % | $ 7.55 B |  Australia |
 |
Biophytis SA
BPTS
|
525 M | - | -13.47 % | $ 169 M |  France |
 |
Институт стволовых клеток человека
ISKJ
|
14.1 M | - | - | - |  Russia |
 |
BioVie
BIVI
|
-12.6 M | $ 1.37 | -5.21 % | $ 2.02 M | USA |
 |
ARCA biopharma
ABIO
|
436 M | - | 1052.0 % | $ 415 M | USA |
 |
Acasti Pharma
ACST
|
24 M | - | 4.01 % | $ 150 M | Canada |
 |
Adaptimmune Therapeutics plc
ADAP
|
2.15 B | - | -15.15 % | $ 60.3 M | Britain |
 |
BioNTech SE
BNTX
|
-6.64 B | $ 93.82 | -1.04 % | $ 27.2 B | Germany |
 |
Aeglea BioTherapeutics
AGLE
|
725 M | - | - | $ 1.01 B | USA |
 |
Albireo Pharma
ALBO
|
417 M | - | -0.23 % | $ 916 M | USA |
 |
Alpine Immune Sciences
ALPN
|
363 M | - | - | $ 2.17 B | USA |
 |
Ampio Pharmaceuticals
AMPE
|
-1.05 M | - | -11.43 % | $ 502 K | USA |
 |
Amphastar Pharmaceuticals
AMPH
|
2 B | $ 26.28 | 3.99 % | $ 1.27 B | USA |
|
Applied Molecular Transport
AMTI
|
7.6 M | - | - | $ 10.1 M | USA |
 |
Anika Therapeutics
ANIK
|
300 M | $ 9.56 | - | $ 140 M | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
647 M | $ 0.27 | -7.19 % | $ 588 M |  Israel |
 |
Arena Pharmaceuticals
ARNA
|
5.65 B | - | -6.81 % | $ 3.04 B | USA |
 |
Athersys
ATHX
|
-37.4 M | - | 3.77 % | $ 22.4 M | USA |
 |
Acer Therapeutics
ACER
|
38.2 M | - | 2.71 % | $ 14 M | USA |
 |
Catalyst Biosciences
CBIO
|
38.1 M | $ 13.75 | -2.41 % | $ 905 M | USA |
 |
Avenue Therapeutics
ATXI
|
-1.23 M | - | -52.27 % | $ 4.45 M | USA |
 |
AVROBIO
AVRO
|
-35.4 M | - | 1083.1 % | $ 745 M | USA |
 |
Axon Enterprise
AXON
|
41.5 B | $ 545.68 | -3.3 % | $ 41.3 B | USA |
 |
Ayala Pharmaceuticals
AYLA
|
5.32 M | - | - | $ 7.46 M | Israel |
 |
Aytu BioScience
AYTU
|
-15.2 M | $ 2.37 | 3.04 % | $ 14.9 M | USA |
 |
AstraZeneca PLC
AZN
|
57.7 B | $ 91.17 | 1.49 % | $ 96.9 B | Britain |
 |
Acorda Therapeutics
ACOR
|
-13.2 M | - | -24.86 % | $ 820 K | USA |
 |
Brickell Biotech
BBI
|
515 K | - | -5.38 % | $ 6.06 M | USA |
 |
Burford Capital Limited
BUR
|
3.22 B | $ 8.9 | -1.22 % | $ 1.45 B | Britain |
 |
BeiGene, Ltd.
BGNE
|
253 B | - | 0.49 % | $ 251 B |  Cayman-islands |
 |
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
10.2 B | $ 11.36 | -1.52 % | $ 735 M | USA |
 |
Biogen
BIIB
|
28.3 B | $ 173.96 | -0.08 % | $ 25.3 B | USA |
 |
Abeona Therapeutics
ABEO
|
184 M | $ 5.09 | -5.13 % | $ 109 M | USA |
 |
Celldex Therapeutics
CLDX
|
18.3 M | $ 27.29 | -0.8 % | $ 1.76 M | USA |
 |
ADiTx Therapeutics
ADTX
|
23.1 M | $ 1.65 | -26.34 % | $ 21.7 K | USA |
 |
Cellectar Biosciences
CLRB
|
60.8 M | $ 3.41 | -5.8 % | $ 41.7 M | USA |
 |
Bellicum Pharmaceuticals
BLCM
|
-9.74 M | - | -9.72 % | $ 5.89 M | USA |
 |
Berkeley Lights
BLI
|
115 M | - | -7.31 % | $ 87 M | USA |
 |
Advaxis
ADXS
|
-3.02 M | - | -9.65 % | $ 45.9 M | USA |
 |
Завод ДИОД
DIOD
|
3.14 B | - | - | - | Russia |
 |
Фармсинтез
LIFE
|
59.3 B | - | - | - | Russia |